These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38841699)

  • 41. Foam sclerotherapy for a symptomatic hepatic cyst: a preliminary report.
    Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):800-4. PubMed ID: 24170168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
    Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
    Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modified Tessari Tourbillon technique for making foam sclerotherapy with silicone-free syringes.
    Whiteley MS; Patel SB
    Phlebology; 2015 Oct; 30(9):614-7. PubMed ID: 25288590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Multiple Factors on Foam Stability in Foam Sclerotherapy.
    Bai T; Jiang W; Chen Y; Yan F; Xu Z; Fan Y
    Sci Rep; 2018 Oct; 8(1):15683. PubMed ID: 30356108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the Safety and Efficacy of Foam Sclerotherapy With 1: 2 Polidocanol to Air Ratio Versus 1: 4 Ratio for the Treatment of Reticular Veins of the Lower Extremities.
    Hoss E; Kollipara R; Boen M; Alhaddad M; Goldman MP
    Dermatol Surg; 2020 Dec; 46(12):1715-1720. PubMed ID: 32947299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Foaming Properties Between the Shirasu Porous Glass Membrane Device and Tessari's Three-way Stopcock Technique for Polidocanol and Ethanolamine Oleate Foam Production: A Benchtop Study.
    Torikai H; Inoue M; Tsukada J; Togawa K; Yamamoto Y; Hase M; Tamura M; Ito N; Soga S; Nakatsuka S; Jinzaki M
    J Vasc Interv Radiol; 2022 May; 33(5):518-524.e3. PubMed ID: 35122940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laser beams interaction with polidocanol foam: molecular background.
    Smarandache A
    Photomed Laser Surg; 2012 May; 30(5):262-7. PubMed ID: 22417110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous Sclerotherapy of Large Venous Malformations Using Consecutive Polidocanol and Bleomycin Foam: MR Imaging Volumetric and Quality-of-Life Assessment.
    Fraissenon A; Fortin F; Durous V; Chauvel-Picard J; Gleizal A; Viremouneix L; Cabet S; Guibaud L
    J Vasc Interv Radiol; 2024 Jan; 35(1):127-136.e1. PubMed ID: 37704038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
    Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
    Bush R; Bush P
    Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
    Markovic JN; Nag U; Shortell CK
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of Syringe Volume on Foam Stability in Sclerotherapy for Varicose Vein Treatment.
    Bai T; Jiang W; Fan Y
    Dermatol Surg; 2018 May; 44(5):689-696. PubMed ID: 29140865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of polidocanol foam administration into rat peripheral veins on pulmonary parenchyma.
    de Moraes Silva MA; Ferreira RG; de Jesus-Silva SG; Cardoso RS; Miranda F
    Phlebology; 2018 Mar; 33(2):122-127. PubMed ID: 28092205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes and predictors of bleomycin polidocanol foam sclerotherapy treatment response in venous malformations.
    Ni B; Liu JW; Fan XQ; He B; Nie QQ; Ye ZD; Liu P; Wen JY
    J Int Med Res; 2024 Jan; 52(1):3000605231223441. PubMed ID: 38258803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of foam sclerotherapy with polidocanol for the management of oral venous malformations.
    Kato T; Katayama Y; Fukuhara S; Watanabe T; Yamanaka S; Nakao K; Morimoto N
    Med Int (Lond); 2024; 4(3):24. PubMed ID: 38595810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized controlled trial to evaluate the safety and efficacy of transluminal injection of foam sclerotherapy compared with ultrasound-guided foam sclerotherapy during endovenous catheter ablation in patients with varicose veins.
    Watanabe S; Okamura A; Iwamoto M; Nagai H; Sumiyoshi A; Tanaka K; Suzuki S; Tanaka H; Iwakura K; Fujii K
    J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):75-81.e1. PubMed ID: 34252576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polidocanol Foam Sclerotherapy Versus Rubber Band Ligation in Hemorrhoidal Disease Grades I/II/III: Randomized Trial.
    Salgueiro P; Garrido M; Santos RG; Pedroto I; Castro-Poças FM
    Dis Colon Rectum; 2022 Jul; 65(7):e718-e727. PubMed ID: 34840294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?
    Lai SW; Goldman MP
    J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.